Search research articles
Contact Us
Filters
Showing results (11-20 of 36) with videos related to
Page
of 4
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1992
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group
B A Gusterson, R D Gelber, A Goldhirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1992
Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group
A M Neville, R Bettelheim, R D Gelber, et al.
British Journal of Cancer
|
April 26, 2012
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
K Ribi, J Aldridge, K-A Phillips, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2011
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial
B Ejlertsen, J Aldridge, K V Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up
M Colleoni, Z Sun, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer
A Ravaioli, F Monti, M M Regan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
M M Regan, O Pagani, B Walley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
E Munzone, A Giobbie-Hurder, B A Gusterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
P Karlsson, B F Cole, B H Chua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 36) with videos related to
Sort By:
Page
of 4
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1992
Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group
B A Gusterson, R D Gelber, A Goldhirsch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 1, 1992
Factors predicting treatment responsiveness and prognosis in node-negative breast cancer. The International (Ludwig) Breast Cancer Study Group
A M Neville, R Bettelheim, R D Gelber, et al.
British Journal of Cancer
|
April 26, 2012
Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer
K Ribi, J Aldridge, K-A Phillips, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 12, 2011
Prognostic and predictive role of ESR1 status for postmenopausal patients with endocrine-responsive early breast cancer in the Danish cohort of the BIG 1-98 trial
B Ejlertsen, J Aldridge, K V Nielsen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 27, 2009
The effect of endocrine responsiveness on high-risk breast cancer treated with dose-intensive chemotherapy: results of International Breast Cancer Study Group Trial 15-95 after prolonged follow-up
M Colleoni, Z Sun, G Martinelli, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 15, 2008
p27 and Skp2 immunoreactivity and its clinical significance with endocrine and chemo-endocrine treatments in node-negative early breast cancer
A Ravaioli, F Monti, M M Regan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 8, 2008
Premenopausal endocrine-responsive early breast cancer: who receives chemotherapy?
M M Regan, O Pagani, B Walley, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 21, 2015
Outcomes of special histotypes of breast cancer after adjuvant endocrine therapy with letrozole or tamoxifen in the monotherapy cohort of the BIG 1-98 trial
E Munzone, A Giobbie-Hurder, B A Gusterson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 11, 2012
Patterns and risk factors for locoregional failures after mastectomy for breast cancer: an International Breast Cancer Study Group report
P Karlsson, B F Cole, B H Chua, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2006
Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)
B C Pestalozzi, D Zahrieh, K N Price, et al.
Page
of 4